When is everolimus indicated for the prevention of liver transplant rejection?

Updated: Dec 31, 2017
  • Author: Lemi Luu, MD, RDMS, FACEP, FAAEM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print


Use of everolimus for liver transplant rejection is not initiated until at least 30 days post liver transplant. Hepatic artery thrombosis has been reported with mTOR inhibitors when they are used within the first 30 days post transplantation.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!